Hot Longevity Mandate: Japan-Based Pharma Company

7 Dec

The company was established as the pharmaceutical arm of a Japanese firm. The firm has a US licensing and clinical development office. The firm also has a Japan-based sales division. The pharma is seeking to form partnerships and in-licensing relationships regarding early stage assets in its key indication areas. These partnerships are highly flexible, and may involve the pharma contributing personnel, sharing studies and research tools, or providing research expense funding.

The pharma is interested in early-stage, first-in-class, orally active small molecule NCEs. The firm seeks assets in the following key areas: Metabolic / Cardiovascular Diseases (NASH, Heart failure (HFrEF, HFpEF, Hypertrophic cardiomyopathy), Diabetic Retinopathy / Diabetic Macular Edema, Chronic Kidney Disease, Sarcopenia), Autoimmune Diseases (Multiple Sclerosis, Lupus, IBD), CNS disorders (Alzheimer’s Disease, Schizophrenia). As well as drugs, the pharma is interested in drug targets in these disease areas. The firm is open to forming partnerships regarding very early stage assets, at or prior to the lead optimization phase. For in-licensing for the Japan market, the company is focused on renal diseases, dermatology and allergic diseases. The compay also invests in drug discovery technologies and research tools such as: technologies related to translational research using cell culture, isolated cellular organelles and related mechanisms; HTS technologies; protein structure analysis; chemical biology, chemical synthesis, and chemical libraries; biophysical tools; in silico technologies; biomarkers and bioinformatics screening, biomarker research, and compound libraries.

The company has no specific company or management team requirements.

If you are interested in more information about this investor and other investors tracked by LSN, please email

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: